CRESTLINE MANAGEMENT, LP VistaGen Therapeutics, Inc. Transaction History

CRESTLINE MANAGEMENT, LP portfolio value:

$53,000
portfolio value

VistaGen Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 call Increase 0.00% 350K shares 53K $0.15 350K